He failed school twice, went to Harvard and changed modern medicine forever – but the Indian scientist never won a Nobel Prize


He failed school twice, went to Harvard and changed modern medicine forever - but the Indian scientist never won a Nobel Prize
Yellapragada Subbarow: The forgotten Indian scientist behind cancer drugs, antibiotics and life-saving medicines

Every year, millions of people around the world take drugs that help fight cancer, treat autoimmune diseases, prevent birth defects or treat bacterial infections. Few of them know that many of these breakthroughs can be traced to the work of an Indian scientist who devoted his life to medical research.his name is Yerapragada Subbaro(Suba Rao).He is not a Nobel Prize winner. He rarely appears in the headlines. Even decades after his death, scientists still consider him one of the most influential biomedical researchers of the 20th century. His story is one of perseverance, scientific curiosity and an unwavering desire to prevent others from suffering like his own family.

A childhood shaped by personal loss

Subbaro was born on January 12, 1895 in Bhimavaram in present-day Andhra Pradesh and grew up in a simple environment. His father, a Sanskrit scholar, died when he was young from tropical sprue, a disease about which little was known at the time. Two of his brothers also died of illness.These personal tragedies left a deep impression on him. They inspired his determination to study medicine and understand the diseases that claimed the lives of his loved ones.However, his path to education was far from smooth. He failed two school exams and finally passed on the third. Financial constraints made higher education difficult, and his future father-in-law was known to support him by helping him purchase medical textbooks.After completing his medical education in India, Subbarro traveled to the United States in 1922 with extraordinary ambitions despite limited financial resources – to pursue scientific research that would improve human health.

The Harvard Years and Discoveries That Transformed Science

At Harvard Medical School, Subaro joined the Department of Biochemistry and began working with biochemist Cyrus Fisk.Together they developed the Fiske-Subbarow method, a laboratory technique for estimating phosphorus content in biological samples. Introduced in the 1920s, this method became one of the most widely used methods in biochemistry and remains important in laboratory medicine today.Subbarow also played a pioneering role in advancing scientists’ understanding of phosphorus-containing compounds involved in intracellular energy transfer, including adenosine triphosphate (ATP). ATP is now considered the primary energy-carrying molecule in living organisms and is the basis of modern biology.Although his scientific contributions earned him widespread respect in the research community, the recognition he received during his lifetime was not always commensurate with the scale of his work.

Scientists’ work continues to save lives

In 1940, Subbarow joined Lederle Laboratories in New York, where he led research that had a lasting impact on medicine.One of his most important contributions was work related to folate, a vitamin that plays a vital role in cell growth and development. Today, folic acid supplementation during pregnancy is recommended worldwide as it helps reduce the risk of neural tube defects in the baby.His research also laid the foundation for aminopterin, one of the first drugs shown to put leukemia in remission in children. This groundbreaking work eventually led to the development of methotrexate, which remains an essential treatment for many types of cancer, as well as diseases such as rheumatoid arthritis and psoriasis.Subaro’s leadership also contributed to the discovery of chlortetracycline, the first tetracycline antibiotic. This breakthrough opened the door to an entire family of antibiotics that continue to be used around the world to fight various bacterial infections.Another major achievement was the development of diethylcarbamazine (DEC), a drug that played a crucial role in controlling lymphatic filariasis, commonly known as elephantiasis. Even today, the World Health Organization recommends DEC as part of a program aimed at eliminating the disease in several countries.

His legacy continues long after his death

Yellapragada Subbarow died in New York on August 8, 1948, at the age of 53.Although he did not receive some of the honors that later scientists in related fields received, his influence on biomedical research grew stronger over time. Historians of science and medical researchers generally acknowledge that his discoveries helped shape modern pharmacology and improved the lives of countless patients around the world.India commemorates his contribution in many ways, including issuing commemorative stamps on the centenary of his birth. His life story is also taught in many medical and scientific institutions as an example of perseverance and research excellence.Yerapragada Subaru’s journey reminds us that the greatest scientific achievements do not always come with fame. Sometimes the most extraordinary legacies are not found in history books or award ceremonies, but in medicines that silently save lives every day.Disclaimer: This article is based on publicly available historical records, scientific literature, and information about the life and contributions of Yellapragada Subbarow. This article is for educational and informational purposes only.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *